{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:38:25Z","timestamp":1788871105737,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Technology of China","award":["2011CB964801"],"award-info":[{"award-number":["2011CB964801"]}]},{"name":"Ministry of Science and Technology of China","award":["2012CB966604"],"award-info":[{"award-number":["2012CB966604"]}]},{"name":"Ministry of Science and Technology of China","award":["2011ZX09102-010-04"],"award-info":[{"award-number":["2011ZX09102-010-04"]}]},{"name":"Ministry of Science and Technology of China","award":["2010CB945204"],"award-info":[{"award-number":["2010CB945204"]}]},{"name":"Ministry of Science and Technology of China","award":["2013BAI01B09"],"award-info":[{"award-number":["2013BAI01B09"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81090410"],"award-info":[{"award-number":["81090410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30825017"],"award-info":[{"award-number":["30825017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81130074"],"award-info":[{"award-number":["81130074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81070390"],"award-info":[{"award-number":["81070390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81170470"],"award-info":[{"award-number":["81170470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81300436"],"award-info":[{"award-number":["81300436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.leukres.2013.09.007","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T03:36:14Z","timestamp":1379475374000},"page":"1592-1601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Distinct sensitivity of CD8+CD4\u2212 and CD8+CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model"],"prefix":"10.1016","volume":"37","author":[{"given":"Yingchi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.09.007_bib0005","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience","volume":"21","author":"Goldberg","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0010","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital","volume":"104","author":"Pui","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0015","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.V73.5.1247.1247","article-title":"Prethymic phenotype and genotype of pre-T (CD7+\/ER\u2212)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia","volume":"73","author":"Thiel","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","article-title":"Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia","volume":"6","author":"Grabher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2013.09.007_bib0025","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/leu.2010.203","article-title":"The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function","volume":"24","author":"Kox","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.09.007_bib0030","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1200\/JCO.2005.05.047","article-title":"Molecular genetics of acute lymphoblastic leukemia","volume":"23","author":"Armstrong","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0035","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1038\/sj.onc.1210766","article-title":"Mechanisms of transcription factor deregulation in lymphoid cell transformation","volume":"26","author":"O\u2019Neil","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2013.09.007_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2013.09.007_bib0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90170-1","article-title":"A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma","volume":"83","author":"Winandy","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2013.09.007_bib0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.leukres.2013.09.007_bib0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm2009","article-title":"Notch signalling: a simple pathway becomes complex","volume":"7","author":"Bray","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0060","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.0603371103","article-title":"Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice","volume":"103","author":"Klinakis","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2013.09.007_bib0065","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1128\/MCB.21.17.5925-5934.2001","article-title":"Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic)","volume":"21","author":"Ronchini","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0070","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1093\/nar\/gkm477","article-title":"Delta-Notch \u2013 and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors","volume":"35","author":"Fischer","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.leukres.2013.09.007_bib0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/MCB.26.1.209-220.2006","article-title":"Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice","volume":"26","author":"Dumortier","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0080","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2005-09-3551","article-title":"Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms","volume":"107","author":"Reschly","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 mutations in mouse models of T-ALL","volume":"107","author":"O\u2019Neil","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0090","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2013.09.007_bib0095","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.leukres.2013.09.007_bib0100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2006-08-039883","article-title":"Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia","volume":"110","author":"Chan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0105","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2013.09.007_bib0110","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2013.09.007_bib0115","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0120","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2013.09.007_bib0125","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0130","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/cncr.23819","article-title":"Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia","volume":"113","author":"O\u2019Brien","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2013.09.007_bib0135","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2010-08-300343","article-title":"Notch1 inhibition targets the leukemia-initiating cells in a Tal1\/Lmo2 mouse model of T-ALL","volume":"118","author":"Tatarek","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0140","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1182\/blood-2010-05-286658","article-title":"Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL","volume":"116","author":"Jeannet","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0145","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1084\/jem.20081561","article-title":"Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1","volume":"205","author":"Li","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2013.09.007_bib0150","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2009-06-227843","article-title":"Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model","volume":"114","author":"Hu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0167-5699(89)90192-8","article-title":"Enrichment of murine haemopoietic stem cells: diverging roads","volume":"10","author":"Spangrude","year":"1989","journal-title":"Immunol Today"},{"key":"10.1016\/j.leukres.2013.09.007_bib0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-199958003-00002","article-title":"Cyclophosphamide and etoposide for non-small cell and small cell lung cancer","volume":"58","author":"Grunberg","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.leukres.2013.09.007_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-006-0336-0","article-title":"A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer","volume":"60","author":"Tabata","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopha.2004.08.006","article-title":"Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)","volume":"58","author":"Nicolini","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.leukres.2013.09.007_bib0175","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ctrv.2010.12.006","article-title":"Oral\/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer: review of the literature","volume":"37","author":"Nelius","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.leukres.2013.09.007_bib0180","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/CAD.0b013e328336acb1","article-title":"Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study","volume":"21","author":"Tanaka","year":"2010","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.leukres.2013.09.007_bib0185","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1182\/blood-2010-04-280818","article-title":"Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim","volume":"116","author":"Happo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.09.007_bib0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.coph.2008.08.004","article-title":"Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises","volume":"8","author":"Yap","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.leukres.2013.09.007_bib0195","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2013.09.007_bib0200","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2013.09.007_bib0205","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.molmed.2007.09.003","article-title":"Right on target: eradicating leukemic stem cells","volume":"13","author":"Krause","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.leukres.2013.09.007_bib0210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.molmed.2007.08.001","article-title":"Targeting the mTOR signaling network in cancer","volume":"13","author":"Chiang","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.leukres.2013.09.007_bib0215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12026-008-8038-9","article-title":"Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease","volume":"42","author":"Brown","year":"2008","journal-title":"Immunol Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261300324X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261300324X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T01:47:21Z","timestamp":1596505641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521261300324X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S014521261300324X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.09.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct sensitivity of CD8+CD4\u2212 and CD8+CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}